ASX:CUV

Clinuvel Pharmaceuticals Limited (CUV.AX) Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range

A$23.00

MA: A$23.00▼

A$23.00

52-Week Range N/A

Volume124,193 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend Yield0.12%

BetaN/A

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering drugs for the treatment of patients with severe genetic and skin disorders worldwide. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity; and PRÃNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with EPP in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.

Overall MarketRank^™

0.65 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Clinuvel Pharmaceuticals Limited (CUV.AX).

2.4 Community Rank

Outperform Votes
Clinuvel Pharmaceuticals Limited (CUV.AX) has received 37 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Clinuvel Pharmaceuticals Limited (CUV.AX) has received 41 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Clinuvel Pharmaceuticals Limited (CUV.AX) has received 52.56% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Clinuvel Pharmaceuticals Limited (CUV.AX) and other stocks. Vote “Outperform” if you believe CUV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CUV will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
Clinuvel Pharmaceuticals Limited (CUV.AX) has a dividend yield of 0.12%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Clinuvel Pharmaceuticals Limited (CUV.AX) does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Clinuvel Pharmaceuticals Limited (CUV.AX) is 9.09%. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Clinuvel Pharmaceuticals Limited (CUV.AX) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange ASX

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolASX:CUV

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.clinuvel.com

Phone61 3 9660 4900

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity Ratio1.79

Current Ratio11.28

Quick Ratio11.01

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$32.57 million

Price / Sales0.00

Cash FlowN/A

Price / Cash Flow19.36

Book ValueA$1.49 per share

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Receive CUV News and Ratings via Email

Sign-up to receive the latest news and ratings for CUV and its competitors with MarketBeat's FREE daily newsletter.

Clinuvel Pharmaceuticals Limited (CUV.AX) (ASX:CUV) Frequently Asked Questions

What stocks does MarketBeat like better than Clinuvel Pharmaceuticals Limited (CUV.AX)?

Wall Street analysts have given Clinuvel Pharmaceuticals Limited (CUV.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Clinuvel Pharmaceuticals Limited (CUV.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How often does Clinuvel Pharmaceuticals Limited (CUV.AX) pay dividends? What is the dividend yield for Clinuvel Pharmaceuticals Limited (CUV.AX)?

Clinuvel Pharmaceuticals Limited (CUV.AX) announced a Final dividend on Friday, August 28th. Investors of record on Friday, September 18th will be paid a dividend of 0.025 per share on Friday, September 18th. This represents a yield of 0.12%. The ex-dividend date of this dividend is Thursday, September 3rd.
View Clinuvel Pharmaceuticals Limited (CUV.AX)'s dividend history.

Is Clinuvel Pharmaceuticals Limited (CUV.AX) a good dividend stock?

Clinuvel Pharmaceuticals Limited (CUV.AX) pays an annual dividend of A$0.03 per share and currently has a dividend yield of 0.12%. The dividend payout ratio of Clinuvel Pharmaceuticals Limited (CUV.AX) is 9.09%. This payout ratio is at a healthy, sustainable level, below 75%.
View Clinuvel Pharmaceuticals Limited (CUV.AX)'s dividend history.

Who are some of Clinuvel Pharmaceuticals Limited (CUV.AX)'s key competitors?

Some companies that are related to Clinuvel Pharmaceuticals Limited (CUV.AX) include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena plc (ABZA.L) (ABZA), Acrux Limited (ACR.AX) (ACR), Actinogen Medical Limited (ACW.AX) (ACW), AdAlta Limited (1AD.AX) (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Alaric (HALB) and Algernon Pharmaceuticals (AGNPF).
View all of CUV's competitors.

What other stocks do shareholders of Clinuvel Pharmaceuticals Limited (CUV.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinuvel Pharmaceuticals Limited (CUV.AX) investors own include Zynga (ZNGA), Worldpay (WP), VolitionRx (VNRX), REA Group Limited (REA.AX) (REA), CSL Limited (CSL.AX) (CSL), Cochlear Limited (COH.AX) (COH), Catabasis Pharmaceuticals (CATB) and Afterpay Limited (APT.AX) (APT).

Who are Clinuvel Pharmaceuticals Limited (CUV.AX)'s key executives?

Clinuvel Pharmaceuticals Limited (CUV.AX)'s management team includes the following people:

Dr. Philippe Jacques Wolgen M.B.A., MBA, M.D., CEO, MD & Director (Age 58, Pay $1.73M)
Mr. Darren M. Keamy, CFO & Company Sec. (Age 48, Pay $372.08k)
Dr. Dennis J. Wright, Chief Scientific Officer
Mr. Malcolm Bull, Head of Investor Relations
Lachlan Hay, Gen. Mang. of Europe

What is Clinuvel Pharmaceuticals Limited (CUV.AX)'s stock symbol?

Clinuvel Pharmaceuticals Limited (CUV.AX) trades on the ASX under the ticker symbol "CUV."

How big of a company is Clinuvel Pharmaceuticals Limited (CUV.AX)?

Clinuvel Pharmaceuticals Limited (CUV.AX) has a market capitalization of $0.00 and generates $32.57 million in revenue each year.

What is Clinuvel Pharmaceuticals Limited (CUV.AX)'s official website?

The official website for Clinuvel Pharmaceuticals Limited (CUV.AX) is www.clinuvel.com.

How can I contact Clinuvel Pharmaceuticals Limited (CUV.AX)?

The company can be reached via phone at 61 3 9660 4900.

This page was last updated on 1/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Clinuvel Pharmaceuticals Limited (CUV.AX) Stock Forecast, Price & News

Adding

Adding

Adding Clinuvel Pharmaceuticals Limited (CUV.AX)

MarketRank™

Overall MarketRank™